Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“When Vascular Fragility Defines Risk: Rethinking Hemostasis in Loeys – Dietz Syndrome
Loeys – Dietz syndrome (LDS) is widely recognized as a connective tissue disorder with aggressive vascular involvement, driven by mutations in the TGF-β signaling pathway.
Yet, beyond aneurysms and dissections, an important question remains insufficiently addressed:
Do we fully understand the hemostatic and perioperative risks in these patients?
Clinical Reality
Patients with LDS often present with:
- Marked arterial tortuosity and aneurysmal disease
- Extreme vascular fragility
- Need for repeated surgical or endovascular interventions
However, intraoperative and postoperative courses may be complicated by:
- Unexpected bleeding
- Tissue friability
- Challenging hemostasis despite ‘normal’ routine labs
The Hidden Hemostasis Dimension
While LDS is not classically categorized as a coagulation disorder, several mechanisms may be clinically relevant:
- Structural vessel wall defects – mechanical bleeding tendency
- Altered extracellular matrix – impaired vascular integrity
- Possible endothelial dysfunction
- Limited evidence regarding platelet – vessel interaction abnormalities
Key Questions for Experts
- Should LDS be considered a functional bleeding-risk condition, even with normal PT/aPTT?
- Is there value in extended hemostasis testing (platelet function, viscoelastic assays)?
- How should we optimize perioperative hemostatic strategies?
- Should antifibrinolytics (e.g., tranexamic acid) be used more proactively?
- Do current surgical protocols sufficiently reflect vascular fragility biology?”
More posts featuring Heghine Khachatryan on Hemostasis Today.
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain
-
Apr 9, 2026, 21:34Chokri Ben Lamine: High-Yield Clinical Insights on Carfilzomib-Induced aHUS
-
Apr 9, 2026, 21:29Satyam Arora: Improving Thalassaemia Care in India Through Ground-Level Data
-
Apr 9, 2026, 20:33Pat Garcia-Gonzalez: On World Health Day, I’m thinking about what ‘health’ really means.
-
Apr 9, 2026, 19:13Jan Sloves: Patterns and Pitfalls Influencing Treatment of Small Saphenous Vein Reflux
-
Apr 9, 2026, 18:38Jecko Thachil: Why D-dimers are Useful Tests for the Exclusion of Thromboembolism and the Diagnosis of DIC
-
Apr 9, 2026, 18:21New Clinical Practice Guideline on Anticoagulant Prophylaxis in Pediatric Patients at Risk of VTE – ISTH